These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28254487)

  • 21. Clinical experiences with 4-hydroxycoumarin anticoagulant No. 63 and the antagonistic effect of menadione and vitamin K.
    HANSON HH; BARKER NW; MANN FD
    Circulation; 1951 Dec; 4(6):844-63. PubMed ID: 14879492
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle.
    Bell RG
    Fed Proc; 1978 Oct; 37(12):2599-604. PubMed ID: 359368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of a target resistance to antivitamin K rodenticides in the roof rat Rattus rattus: identification and characterisation of a novel Y25F mutation in the Vkorc1 gene.
    Goulois J; Chapuzet A; Lambert V; Chatron N; Tchertanov L; Legros L; Benoît E; Lattard V
    Pest Manag Sci; 2016 Mar; 72(3):544-50. PubMed ID: 25847836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.
    Czogalla KJ; Liphardt K; Höning K; Hornung V; Biswas A; Watzka M; Oldenburg J
    Blood Adv; 2018 Mar; 2(6):691-702. PubMed ID: 29581108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of prothrombin synthesis and epoxidation of vitamin K1 by anticoagulants in vitro.
    Bell RG; Stark P
    Biochem Biophys Res Commun; 1976 Sep; 72(2):619-25. PubMed ID: 985502
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new assymetrical vitamin K antagonist: 3-(alpha-naphthyl)-4-hydroxycoumarin].
    MORAUX J; MEUNIER P; MENTZER C
    Arch Int Pharmacodyn Ther; 1953 May; 94(1):47-64. PubMed ID: 13066148
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The function and metabolism of vitamin K.
    Olson RE
    Annu Rev Nutr; 1984; 4():281-337. PubMed ID: 6380538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats.
    Jourdi G; Lefèbvre S; Le Bonniec B; Curis E; Gaussem P; Lattard V; Siguret V
    Pestic Biochem Physiol; 2018 Apr; 146():19-24. PubMed ID: 29626988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.
    Czogalla KJ; Biswas A; Wendeln AC; Westhofen P; Müller CR; Watzka M; Oldenburg J
    Blood; 2013 Oct; 122(15):2743-50. PubMed ID: 23982176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heparins and antivitamins K].
    Langer B
    Rev Paul Med; 1990; 108(4):183-8. PubMed ID: 2095622
    [No Abstract]   [Full Text] [Related]  

  • 33. The characterization of potent novel warfarin analogs.
    Kerr JS; Li HY; Wexler RS; Robinson AJ; Robinson CS; Boswell GA; Krauthauser C; Harlow PP
    Thromb Res; 1997 Oct; 88(2):127-36. PubMed ID: 9361366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical synthesis of hydroxychromenes and evaluation of their biological activity.
    Jung JC; Oh S
    Molecules; 2011 Dec; 17(1):240-7. PubMed ID: 22205090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of prothrombin synthesis by K-vitamins compared in vitamin K-deficient and in brodifacoum-treated rats.
    Craciun AM; Groenen-van Dooren MM; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1998 Mar; 1380(1):75-81. PubMed ID: 9545541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants.
    Hodroge A; Longin-Sauvageon C; Fourel I; Benoit E; Lattard V
    Arch Biochem Biophys; 2011 Nov; 515(1-2):14-20. PubMed ID: 21907178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacological review of dicoumarol: An old natural anticoagulant agent.
    Sun C; Zhao W; Wang X; Sun Y; Chen X
    Pharmacol Res; 2020 Oct; 160():105193. PubMed ID: 32911072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of zeta-crystallin by Coumarins: a structure-activity study.
    Duhaiman AS
    J Protein Chem; 1996 Apr; 15(3):261-4. PubMed ID: 8804573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin K and gamma-carboxyglutamate biosynthesis.
    Olson RE; Suttie JW
    Vitam Horm; 1977; 35():59-108. PubMed ID: 343363
    [No Abstract]   [Full Text] [Related]  

  • 40. [How to improve the monitoring of anticoagulant therapy with antivitamins K. Recommendation of the Study Group on Hemostasis and Thrombosis].
    Rev Fr Gynecol Obstet; 1987 Feb; 82(2):133-4. PubMed ID: 3563287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.